Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
1 clinical trials · Condition
◉ Watch Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
| Record | Firm | Date |
|---|---|---|
| Efficacy of Lenalidomide Maintenance in Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma: a Phase II, Open-label, Single-arm Study (NCT05901324) | National Taiwan University Hospital | 2023-07-01 |
Track Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.